DK0804164T3 - Fremgangsmåde til priming af en immunreaktion i et 1 dag gammelt dyr - Google Patents

Fremgangsmåde til priming af en immunreaktion i et 1 dag gammelt dyr

Info

Publication number
DK0804164T3
DK0804164T3 DK95938205T DK95938205T DK0804164T3 DK 0804164 T3 DK0804164 T3 DK 0804164T3 DK 95938205 T DK95938205 T DK 95938205T DK 95938205 T DK95938205 T DK 95938205T DK 0804164 T3 DK0804164 T3 DK 0804164T3
Authority
DK
Denmark
Prior art keywords
priming
immune response
day old
old animal
animal
Prior art date
Application number
DK95938205T
Other languages
Danish (da)
English (en)
Inventor
Daryll A Emery
Darren E Straub
Richard Huisinga
Original Assignee
Willmar Poultry Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Willmar Poultry Co Inc filed Critical Willmar Poultry Co Inc
Application granted granted Critical
Publication of DK0804164T3 publication Critical patent/DK0804164T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DK95938205T 1994-07-07 1995-02-02 Fremgangsmåde til priming af en immunreaktion i et 1 dag gammelt dyr DK0804164T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/272,116 US5538733A (en) 1994-07-07 1994-07-07 Method of priming an immune response in a one-day old animal
PCT/US1995/001304 WO1996001620A1 (fr) 1994-07-07 1995-02-02 Procede d'amorcage de reponse immunitaire chez un animal age d'un jour

Publications (1)

Publication Number Publication Date
DK0804164T3 true DK0804164T3 (da) 2002-11-04

Family

ID=23038473

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95938205T DK0804164T3 (da) 1994-07-07 1995-02-02 Fremgangsmåde til priming af en immunreaktion i et 1 dag gammelt dyr

Country Status (8)

Country Link
US (2) US5538733A (fr)
EP (1) EP0804164B8 (fr)
AU (1) AU1738795A (fr)
CA (1) CA2194448C (fr)
DE (1) DE69527804T2 (fr)
DK (1) DK0804164T3 (fr)
ES (1) ES2181798T3 (fr)
WO (1) WO1996001620A1 (fr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7279162B1 (en) 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
US5919466A (en) * 1993-10-01 1999-07-06 Gerbu Biotechnik Gmbh Method for improving the yield of immunoantibodies in the vaccination of animals and humans
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
DK0749321T3 (da) * 1994-02-09 2007-03-12 Epitopix Llc Aktiv immunisering under anvendelse af et sideroforreceptorprotein
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
DK0770397T3 (da) * 1995-10-18 2004-08-09 Akzo Nobel Nv Newcastle disease viruskombinationsvaccine
US5858378A (en) * 1996-05-02 1999-01-12 Galagen, Inc. Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US6969520B2 (en) * 1997-10-20 2005-11-29 Acambis Inc. Active immunization against clostridium difficile disease
US6136794A (en) * 1998-02-02 2000-10-24 Merck & Co., Inc. Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist
TR200003225T2 (tr) * 1998-03-02 2001-02-21 Applied Vaccine Technologies Copr. Bağışıklık tepkisini modüle etmek için yöntemler ve araçlar
US6506385B1 (en) 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US6342231B1 (en) * 1998-07-01 2002-01-29 Akzo Nobel N.V. Haemophilus parasuis vaccine and diagnostic
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
US6641820B1 (en) * 2000-01-19 2003-11-04 Allergan, Inc. Clostridial toxin derivatives and methods to treat pain
US6500436B2 (en) 2000-01-19 2002-12-31 Allergan, Inc. Clostridial toxin derivatives and methods for treating pain
US7138127B1 (en) 2000-01-19 2006-11-21 Allergan, Inc. Clostridial toxin derivatives and methods for treating pain
EP2289550A3 (fr) * 2000-01-27 2012-02-15 MedImmune, LLC Anticorps à neutralisation d'ultra haute affinité
DK1259547T3 (da) 2000-03-01 2012-10-15 Medimmune Inc Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
EP1276499A2 (fr) * 2000-04-25 2003-01-22 Wyeth Vaccin contre la myeloencephalite protozoaire du cheval
WO2001087233A2 (fr) * 2000-05-16 2001-11-22 New York University Anticorps anti-idiotypes diriges contre l'adhesine fimh d'escherichia coli uropathogene fimbrie du type i, compositions le contenant et son procede d'utilisation
US6306423B1 (en) * 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US20040033241A1 (en) * 2000-06-02 2004-02-19 Allergan, Inc. Controlled release botulinum toxin system
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US6855493B2 (en) 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MXPA03006038A (es) * 2001-01-03 2005-02-14 Willmar Poultry Co Inc Composiciones inmunizantes y metodos de uso.
US7923023B2 (en) * 2002-02-25 2011-04-12 Astech International LLC Method and composition for delivery of medicants to animals
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
WO2004093903A2 (fr) * 2003-04-18 2004-11-04 The Brigham And Women's Hospital, Inc. Procedes et compositions d'immunomodulation mettant en oeuvre des antigenes cd1
AU2004274977B2 (en) 2003-09-19 2011-06-23 Epitopix, Llc Campylobacter polypeptides and methods of use
US8029454B2 (en) 2003-11-05 2011-10-04 Baxter International Inc. High convection home hemodialysis/hemofiltration and sorbent system
WO2005123120A1 (fr) * 2004-06-16 2005-12-29 Smart Drug Systems Inc. Composition vaccinale à libération prolongée
US9458204B2 (en) * 2004-08-25 2016-10-04 Epitopix Llc Fusobacterium polypeptides and methods of use
WO2006050166A2 (fr) * 2004-10-29 2006-05-11 Medimmune, Inc. Methodes de prevention et de traitement des infections a rsv et des etats pathologiques associes
NZ556651A (en) 2005-01-21 2010-05-28 Epitopix Llc Yersinia spp. polypeptides and methods of use
US8007811B2 (en) * 2005-02-14 2011-08-30 Epitopix, Llc Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
WO2007070660A2 (fr) 2005-12-13 2007-06-21 President And Fellows Of Harvard College Echafaudages pour transplantation cellulaire
CA2667890C (fr) * 2006-10-31 2015-01-27 Surmodics Pharmaceuticals, Inc. Particules polymeres mises sous forme de spheres
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
EP1997830A1 (fr) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. Molécules à liaison spécifiques RSV et leur moyen de fabrication
US20090104234A1 (en) * 2007-10-23 2009-04-23 Allergan, Inc. Methods of treating chronic neurogenic inflammation using modified clostridial toxins
US8114276B2 (en) 2007-10-24 2012-02-14 Baxter International Inc. Personal hemodialysis system
CN102006891B (zh) 2008-02-13 2017-04-26 哈佛学院董事会 连续的细胞程序化装置
BRPI1011856A2 (pt) 2009-03-23 2020-11-03 Epitopix, Llc polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
CN107648668B (zh) 2010-10-06 2021-06-18 哈佛学院董事会 用于基于材料的细胞疗法的可注射的成孔水凝胶
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
WO2013009843A1 (fr) * 2011-07-11 2013-01-17 Camas Incorporated Compositions contre des toxines bactériennes
DK2838515T3 (da) 2012-04-16 2020-02-24 Harvard College Mesoporøse siliciumdioxidsammensætninger til modulering af immunresponser
US10100093B2 (en) 2013-12-31 2018-10-16 Epitopix Llc Polypeptides and immunizing compositions containing Burkholderia polypeptides and methods of use
EP3137105A4 (fr) 2014-04-30 2017-12-27 President and Fellows of Harvard College Dispositifs de vaccin combiné et procédés de destruction de cellules cancéreuses
US11786457B2 (en) 2015-01-30 2023-10-17 President And Fellows Of Harvard College Peritumoral and intratumoral materials for cancer therapy
WO2016164705A1 (fr) 2015-04-10 2016-10-13 Omar Abdel-Rahman Ali Dispositifs de piégeage de cellules immunitaires et leurs procédés de fabrication et d'utilisation
US11000582B2 (en) 2015-07-10 2021-05-11 Epitopix, Llc Proteins and immunizing compositions containing klebsiella proteins and methods of use
WO2017083367A1 (fr) 2015-11-09 2017-05-18 Epitopix, Llc Polypeptides de fusobacterium et leurs procédés d'utilisation
US11752238B2 (en) 2016-02-06 2023-09-12 President And Fellows Of Harvard College Recapitulating the hematopoietic niche to reconstitute immunity
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
CN109789092A (zh) 2016-07-13 2019-05-21 哈佛学院院长等 抗原呈递细胞模拟支架及其制备和使用方法
IL264557B2 (en) 2016-08-02 2024-01-01 Harvard College Biological agents for regulating immune responses
ES2945137T3 (es) 2017-02-10 2023-06-28 Epitopix Llc Proteínas y composiciones inmunitarias que contienen proteínas de Pasteurella y métodos de uso
WO2019147947A2 (fr) 2018-01-25 2019-08-01 Epitopix, Llc Protéines modifiées et procédés d'utilisation
WO2020061129A1 (fr) 2018-09-19 2020-03-26 President And Fellows Of Harvard College Compositions et procédés de marquage et de modulation de cellules in vitro et in vivo
WO2021061837A1 (fr) 2019-09-23 2021-04-01 President And Fellows Of Harvard College Vaccin sans antigène à base de biomatériau et son utilisation
US20240115685A1 (en) * 2020-12-22 2024-04-11 Intervet Inc. Conjugated fumonisin to protect against mycotoxicosis
JP2024540240A (ja) 2021-10-29 2024-10-31 ヴァクシノヴァ ユーエス， インコーポレイテッド 感染症を防止するための方法および組成物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887699A (en) * 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
US3975350A (en) * 1972-08-02 1976-08-17 Princeton Polymer Laboratories, Incorporated Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles
US4180560A (en) * 1976-10-26 1979-12-25 Syntex Corporation Inert core implant pellet
US4756907A (en) * 1978-10-17 1988-07-12 Stolle Research & Development Corp. Active/passive immunization of the internal female reproductive organs
US4326523A (en) * 1980-08-25 1982-04-27 International Minerals & Chemical Corp. Method of supplying micronutrients to animals
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4680174A (en) * 1984-05-24 1987-07-14 Damon Biotech, Inc. Induction of immune response by immunization with encapsulated antigen-producing cells
IL74289A (en) * 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
US4863735A (en) * 1985-02-19 1989-09-05 Massachusetts Institute Of Technology Biodegradable polymeric drug delivery system with adjuvant activity
US4732971A (en) * 1985-06-03 1988-03-22 Eli Lilly And Company Synthetic vaccines for foot and mouth disease
US4732155A (en) * 1985-08-27 1988-03-22 The Children's Medical Center Corporation Implantable chemoattractant system
US5026365A (en) * 1987-04-29 1991-06-25 The University Of Massachusetts Method and apparatus for therapeutically treating immunological disorders and disease states
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US4837202A (en) * 1987-09-14 1989-06-06 Pitman-Moore, Inc. Method for stimulating the immune system
US5271945A (en) * 1988-07-05 1993-12-21 Takeda Chemical Industries, Ltd. Sustained release microcapsule for water soluble drug
US5015476A (en) * 1989-08-11 1991-05-14 Paravax, Inc. Immunization implant and method
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
US5352448A (en) * 1992-07-20 1994-10-04 Purdue Research Foundatioin Oral administration of antigens
US5420253A (en) * 1993-09-09 1995-05-30 Willmar Poultry Company, Inc. Method for purifying egg yolk immunoglobulins
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal

Also Published As

Publication number Publication date
CA2194448A1 (fr) 1996-01-25
EP0804164A4 (fr) 1998-08-05
EP0804164A2 (fr) 1997-11-05
WO1996001620A1 (fr) 1996-01-25
DE69527804T2 (de) 2003-05-08
EP0804164B8 (fr) 2003-01-15
ES2181798T3 (es) 2003-03-01
AU1738795A (en) 1996-02-09
DE69527804D1 (de) 2002-09-19
US5906826A (en) 1999-05-25
US5538733A (en) 1996-07-23
CA2194448C (fr) 2010-03-23
EP0804164B1 (fr) 2002-08-14

Similar Documents

Publication Publication Date Title
DK0804164T3 (da) Fremgangsmåde til priming af en immunreaktion i et 1 dag gammelt dyr
DE69623479D1 (de) Fernmeldeanordnung und -verfahren
EP0654943A3 (fr) Procédé et circuit d'amélioration d'image.
DE69629389D1 (de) Interaktive bildaufbereitung
FI910722A7 (fi) Menetelmä keratiinin hydrolysoimiseksi
FI970059A7 (fi) Menetelmä immunifunktion säätelemiseksi
EP0920014A4 (fr) Dispositif d'edition et procede d'edition
ITBO950015A0 (it) Endoprotesi coronarica e metodo per la sua realizzazione
FI970670L (fi) Polttomenetelmä
DE69605168D1 (de) Einspritzventil
DE69604230D1 (de) Pumpeinheit und -verfahren
FI973484A7 (fi) Menetelmä immuunivasteen stimuloimiseksi
DK0877548T3 (da) Fremgangsmåde til malkning af et dyr og en malkemaskine
ATA132494A (de) Pflanzstab-fixiereinrichtung
KR19980703792A (ko) 곤충 유인 및 박멸 방법
ITTO911046A1 (it) Metodo di sgrassaggio-pulitura
DE69212819D1 (de) Aufbaumethode und -vorrichtung
DE69618914D1 (de) Brennstoff-Einspritzvorrichtung und -verfahren
DE59602366D1 (de) Einspritzdüse
FI954832A0 (fi) Uuttomenetelmä
KR960012294A (ko) 노광방법 및 스테퍼
DE59606137D1 (de) Einspritzeinrichtung
EP0619526A3 (fr) Elément photosensible et son procédé.
FI924026A7 (fi) Emulsiota hyväksikäyttävä agglomeraatiomenetelmä
FR2724988B1 (fr) Element et procede d'assemblage